Celularity Inc - Class A

Research Celularity Inc - Class A (CELU) on Bullrun: market cap USD 17.55M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCELU
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 17.55M
• Financial periodFY2025
• RevenueUSD 26.55M
• Revenue growth-51.0%
• Net income-USD 91.72M
• Gross margin24.4%

Valuation Snapshot

latest market cap is USD 17.55M.

About Celularity Inc - Class A

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease;

Frequently asked questions

What is Celularity Inc - Class A's market cap?

Celularity Inc - Class A's market capitalization is USD 17.55M.

What does Celularity Inc - Class A do?

Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking.